Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Be prepared....c.AGN will sink back into the teens :(

<< Previous

Bullboard Posts

Next >>

Comment by Mole101on Dec 19, 2020 11:43pm

189 Views

Post# 32148422

RE:Be prepared....c.AGN will sink back into the teens :(

IT doesn’t mater if it goes down more...more shares to be purchases at a better price and a great opportunity to accumulate... the SP will be heading up ones again as the final readout for P2 gets closer.. same or maybe even higher than this past time ... it’s like an old movie.,. the question is how long will you stay in or how much you take out ...

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing